top of page

Publications

"Leaving the decision step to me": School Naloxone Policies Developed and Implemented by District and School Nurses

It's not in stock: Community pharmacists' decision-making and communication when refusing to dispense controlled substance prescriptions

Increasing Buprenorphine and Naloxone Access in Texas Community Pharmacies Through an Academic Detailing Intervention

Predictors of incident anxiety and stress-related diagnoses following buprenorphine initiation among commercially insured patients with opioid use disorder

Tyler J. Varisco, Abolfazl Sadeghi, Lindsey Loera, Kiyoung Kim, Sophia Rhoades, J. Douglas Thornton, Smita Prasad 

How Do We Increase Treatment for Alcohol Use Disorder in Primary Care? It Takes a Team

Addressing wholesale distributor barriers to buprenorphine access: Consensus recommendations from the PhARM-OUD expert panel

Buprenorphine Adherence Trajectories and Their Impact on Opioid Overdose and Healthcare Costs

Prediction of Antipsychotic Associated Weight Gain in Children and Adolescents Taking Second Generation Antipsychotics: A Machine Learning Approach

Gaps in buprenorphine access: Examining provider availability and treatment continuity

Abolfazl Sadeghi, J. Douglas Thornton, Tyler J. Varisco

In Support of a Public Health Approach to Drug Policy: Position Statement of AMERSA, Inc

bottom of page